Redundant function of the heparan sulfate 6-O-endosulfatases Sulf1 and Sulf2 during skeletal development

Developmental Dynamics

Volumn 237, Issue 2, 2008, Pages 339-353

  Ratzka, Andreas ^a,d   Kalus, Ina ^b   Moser, Markus ^c   Dierks, Thomas ^b   Mundlos, Stefan ^d   Vortkamp, Andrea ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b BIELEFELD UNIVERSITY   (Germany)

^c MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

^d MAX PLANCK INSTITUTE FOR MOLECULAR GENETICS   (Germany)

Author keywords

Bone; Cartilage; Chondrocyte differentiation; Endochondral ossification; Heparan sulfate; Mouse; Sulf1; Sulf2; Sulfatase

Indexed keywords

HEPARAN SULFATE; HEPARAN SULFATE 6 O ENDOSULFATASE SULF1; HEPARAN SULFATE 6 O ENDOSULFATASE SULF2; SULFATASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE DEVELOPMENT; CARTILAGE CELL; CELL DIFFERENTIATION; CONTROLLED STUDY; EMBRYO DEVELOPMENT; EMBRYO PATTERN FORMATION; ENCHONDRAL OSSIFICATION; ENZYME ACTIVITY; FETUS; GENE FUNCTION; MOUSE; NEWBORN; NONHUMAN; NUCLEOTIDE SEQUENCE; OSSIFICATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SULFATION; VERTEBRA;

EID: 39749201086     PISSN: 10588388     EISSN: 10970177     Source Type: Journal    
DOI: 10.1002/dvdy.21423     Document Type: Article

References (42)

1. Ai X, Do AT, Lozynska O, Kusche‐Gullberg M, Lindahl U, Emerson CP Jr. 2003. QSulf1 remodels the 6‐O sulfation states of cell surface heparan sulfate proteoglycans to promote Wnt signaling. J Cell Biol 162: 341–351.
2. Ai X, Kitazawa T, Do AT, Kusche‐Gullberg M, Labosky PA, Emerson CP Jr. 2007. SULF1 and SULF2 regulate heparan sulfate‐mediated GDNF signaling for esophageal innervation. Development 134: 3327–3338.
3. Ashikari‐Hada S, Habuchi H, Kariya Y, Itoh N, Reddi AH, Kimata K. 2004. Characterization of growth factor‐binding structures in heparin/heparan sulfate using an octasaccharide library. J Biol Chem 279: 12346–12354.
4. Brent AE, Schweitzer R, Tabin CJ. 2003. A somatic compartment of tendon progenitors. Cell 113: 235–248.
5. Brito JM, Teillet MA, Le Douarin NM. 2006. An early role for Sonic hedgehog from foregut endoderm in jaw development: Ensuring neural crest cell survival. Proc Natl Acad Sci USA 103: 11607–11612.
6. Bullock SL, Fletcher JM, Beddington RSP, Wilson VA. 1998. Renal agenesis in mice homozygous for a gene trap mutation in the gene encoding heparan sulfate 2‐sulfotransferase. Genes Dev 12: 1894–1906.
7. Chen JM. 1952. Studies on the morphogenesis of the mouse sternum. I. Normal embryonic development. J Anat Lond 86: 373–386.
8. Chen JM. 1953. Studies on the morphogenesis of the mouse sternum. III. Experiments on the closure and segmentation of the sternal bands. J Anat Lond 87: 130–149.
9. Chiang C, Litingtung Y, Lee E, Young KE, Corden JL, Westphal H, Beachy PA, 1996. Cyclopia and defective axial patterning in mice lacking sonic hedgehog gene function. Nature 383: 407–413.
10. Danesin C, Agius E, Escalas N, Ai X, Emerson C, Cochard P, Soula C. 2006. Ventral neural progenitors switch toward an oligodendroglial fate in response to increased sonic hedgehog (Shh) activity: involvement of sulfatase 1 in modulating Shh signaling in the ventral spinal cord. J Neurosci 26: 5037–5048.
11. Dhoot GK, Gustafsson MK, Ai X, Sun W, Standiford DM, Emerson CP Jr. 2001. Regulation of Wnt signaling and embryo patterning by an extracellular sulfatase. Science 293: 1663–1666.
12. Farach‐Carson MC, Hecht JT, Carson DD. 2005. Heparan sulfate proteoglycans: key players in cartilage biology. Crit Rev Eukaryot Gene Expr 15: 29–48.
13. Goldring MB, Tsuchimochi K, Ijiri K. 2006. The control of chondrogenesis. J Cell Biochem 97: 33–44.
14. Gorsi B, Stringer SE. 2007. Tinkering with heparan sulfate sulfation to steer development. Trends Cell Biol 17: 173–177.
15. Grobe K, Inatani M, Pallerla SR, Castagnola J, Yamaguchi Y, Esko JD. 2005. Cerebral hypoplasia and craniofacial defects in mice lacking heparan sulfate Ndst1 gene function. Development 132: 3777–3786.
16. Holst CR, Bou‐Reslan H, Gore BB, Wong K, Grant D, Chalasani S, Carano RA, Frantz GD, Tessier‐Lavigne M, Bolon B, French DM, Ashkenazi A. 2007. Secreted sulfatases Sulf1 and Sulf2 have overlapping yet essential roles in mouse neonatal survival. PLoS one e575: 1–14.
17. Hu Z, Yu M, Hu G. 2007. NDST‐1 modulates BMPR and PTHrP signaling during endochondral bone formation in a gene knockout model. Bone 40: 1462–1474.
18. Koziel L, Kunath M, Kelly OG, Vortkamp A. 2004. Ext1‐dependent heparan sulfate regulates the range of Ihh signaling during endochondral ossification. Dev Cell 6: 801–813.
19. Kronenberg HM. 2003. Developmental regulation of the growth plate. Nature 423: 332–336.
20. Lamanna WC, Baldwin RJ, Padva M, Kalus I, ten Dam G, van Kuppevelt TH, Gallagher JT, von Figura K, Dierks T, Merry CLR. 2006. Heparan sulfate 6‐O‐endosulfatases: discrete in vivo activities and functional co‐operativity. Biochem J 400: 63–73.
21. Lamanna WC, Kalus I, Padva M, Baldwin RJ, Merry CLR, Dierks T. 2007. The heparanome: the enigma of encoding and decoding heparan sulfate sulfation. J Biotechnol 129: 290–307.
22. Ledin J, Staatz W, Li JP, Götte M, Selleck S, Kjellén L, Spillmann D. 2004. Heparan sulfate structure in mice with genetically modified heparan sulfate production. J Biol Chem 279: 42732–42741.
23. Liu Z, Xu J, Colvin JS, Ornitz DM. 2002. Coordination of chondrogenesis and osteogenesis by fibroblast growth factor 18. Genes Dev 16: 859–869.
24. Lum DH, Tan J, Rosen SD, Werb Z. 2007. Gene trap disruption of the mouse heparan sulfate 6‐O‐endosulfatase gene, Sulf2. Mol Cell Biol 27: 678–688.
25. McLeod MJ. 1980. Differential staining of cartilage and bone in whole mouse fetuses by alcian blue and alizarin red S. Teratology 22: 299–301.
26. Merry CLR, Bullock SL, Swan DC, Backen AC, Lyon M, Beddington RSP, Wilson VA, Gallagher JT. 2001. The molecular phenotype of heparan sulfate in the Hs2st −/− mutant mouse. J Biol Chem 276: 35429–35434.
27. Minina E, Kreschel C, Naski MC, Ornitz DM, Vortkamp A. 2002. Interaction of FGF, Ihh/Pthlh, and BMP signaling integrates chondrocyte proliferation and hypertrophic differentiation. Dev Cell 3: 439–449.
28. Minina E, Schneider S, Rosowski M, Lauster R, Vortkamp A. 2005. Expression of Fgf and Tgfβ signaling related genes during embryonic endochondral ossification. Gene Expr Patterns 6: 102–109.
29. Nagamine S, Koike S, Keino‐Masu K, Masu M. 2005. Expression of a heparan sulfate remodeling enzyme, heparan sulfate 6‐O‐endosulfatase sulfatase FP2, in the rat nervous system. Dev Brain Res 159: 135–143.
30. Naski MC, Colvin JS, Coffin JD, Ornitz DM. 1998. Repression of hedgehog signaling and BMP4 expression in growth plate cartilage by fibroblast growth factor receptor 3. Development 125: 4977–4988.
31. Nawroth R, van Zante A, Cervantes S, McManus M, Hebrok M, Rosen SD. 2007. Extracellular sulfatases, elements of the Wnt signaling pathway, positively regulate growth and tumorigenicity of human pancreatic cancer cells. PLoS one e392: 1–9.
32. Noti C, de Paz JL, Polito L, Seeberger PH. 2006. Preparation and use of microarrays containing synthetic heparin oligosaccharides for the rapid analysis of heparin‐protein interactions. Chem Eur J 12: 8664–8686.
33. Ohto T, Uchida H, Yamazaki H, Keino‐Masu K, Matsui A, Masu M. 2002. Identification of a novel nonlysosomal sulphatase expressed in the floor plate, choroid plexus and cartilage. Genes Cells 7: 173–185.
34. Schwartz NB, Domowicz M. 2002. Chondrodysplasias due to proteoglycan defects. Glycobiology 12: 57R–68R.
35. Storm EE, Kingsley DM. 1996. Joint patterning defects caused by single and double mutations in members of the bone morphogenetic protein (BMP) family. Development 122: 3969–3979.
36. Stricker S, Verhey van Wijk N, Witte F, Brieske N, Seidel K, Mundlos S. 2006. Cloning and expression pattern of chicken Ror2 and functional characterization of truncating mutations in Brachydactyly type B and Robinow syndrome. Dev Dyn 235: 3456–3465.
37. Stryke D, Kawamoto M, Huang CC, Johns SJ, Leslie A, King LA, Harper CA, Meng EC, Lee RE, Yee A, L'Italien L, Chuang PT, Young SG, Skarnes WC, Babbitt PC, Ferrin TE. 2003. BayGenomics: a resource of insertional mutations in mouse embryonic stem cells. Nucleic Acids Res 31: 278–281.
38. Thiele H, Sakano M, Kitagawa H, Sugahara K, Rajab A, Hohne W, Ritter H, Leschik G, Nurnberg P, Mundlos S. 2004. Loss of chondroitin 6‐O‐sulfotransferase‐1 function results in severe human chondrodysplasia with progressive spinal involvement. Proc Natl Acad Sci USA 101: 10155–10160.
39. Viviano BL, Paine‐Saunders S, Gasiunas N, Gallagher J, Saunders S. 2004. Domain‐specific modification of heparan sulfate by Qsulf1 modulates the binding of the bone morphogenetic protein antagonist noggin. J Biol Chem 279: 5604–5611.
40. Wang S, Ai X, Freeman SD, Pownall ME, Lu Q, Kessler DS, Emerson CP Jr. 2004. QSulf1, a heparan sulfate 6‐O‐endosulfatase, inhibits fibroblast growth factor signaling in mesoderm induction and angiogenesis. Proc Natl Acad Sci USA 101: 4833–4838.
41. Zelzer E, Olsen BR. 2003. The genetic basis for skeletal diseases. Nature 423: 343–348.
42. Zhao W, Sala‐Newby GB, Dhoot GK. 2006. Sulf1 expression pattern and its role in cartilage and joint development. Dev Dyn 235: 3327–3335.